ACADL and hepatocellular carcinoma: More importantly, ACADL-mediated suppressive effect on HCC cell growth was not diminished by etomoxir, the fatty acid oxidation inhibitor, suggesting the existence of other mechanisms independent of its function in fatty acid oxidation.